Panretinal photocoagulation induced alterations in accommodation, pupillary parameters and contrast sensitivity: A prospective study in patients with proliferative diabetic retinopathy
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 50
- 试验地点
- 1
- 主要终点
- 1 To measure the change in pupil size in photopic, mesopic and scotopic illumination conditions after PRP
研究概览
简要总结
Diabetic retinopathy is a serious eye disease caused by diabetes, where high blood sugar levels damage the blood vessels in the retina. Oxidative stress induced hyperglycemia is the key event in the pathogenesis of diabetic retinopathy. This damage can lead to vision impairment and, in advanced stages, blindness. Diabetic retinopathy progresses through various stages as non proliferative diabetic retinopathy NPDR and proliferative diabetic retinopathy PDR. Panretinal photocoagulation PRP is a type of laser treatment used to reduce the risk of severe vision loss in patients with proliferative diabetic retinopathy PDR or other retinal diseases. It involves applying controlled laser burns to peripheral retina, promoting selective photocoagulation, significantly reduces the oxygen demand of peripheral retina, leading to decrease production of vascular endothelial growth factor(VEGF) and other angiogenic factors. The study will evaluate the effect of PRP on accommodation, pupillary parameters and contrast sensitivity before PRP sitting , 1 month and 3 month after completion of PRP. The pupillary parameters will be assessed in photopic, mesopic and scotopic illumination conditions.
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 90.00 Year(s)(—)
- 性别
- All
入选标准
- •1 Eyes with proliferative diabetic retinopathy requiring panretinal photocoagulation 2 Patients willing to give consent for study and follow up 3 Eyes with pupils reacting to light.
排除标准
- •1 Macular edema requiring anti-VEGF therapy 2 Eyes with pupillary abnormalities such as coloboma, iris atropy, rubeosis iridis, sectoral iris loss 3 Eyes with hazy media 4 Eyes with other retinal disorders or optic nerve damage 5 Eyes requiring surgery for advanced diabetic eye disease 6 Past history of cataract surgery 7 Eyes developing vitreous hemorrhage after PRP within 4 months 8 Eyes presenting with posterior synechiae 9 Eyes with non-reacting pupils 10 Eyes with traumatic mydriatic pupils 11 Eyes presenting with pseudoexfoliation syndrome 12 Eyes developing macular edema after PRP (even after 1 month or 1st PRP sitting) 13 Eyes undergoing any surgical interventions before or in between follow-up.
结局指标
主要结局
1 To measure the change in pupil size in photopic, mesopic and scotopic illumination conditions after PRP
时间窗: Recorded before 1st PRP sitting then follow-up 1 month and 3 month after completion of PRP.
2 To measure the change in amplitude of accommodation and change in near point of accommodation following PRP
时间窗: Recorded before 1st PRP sitting then follow-up 1 month and 3 month after completion of PRP.
3 To measure the change in contrast sensitivity following PRP
时间窗: Recorded before 1st PRP sitting then follow-up 1 month and 3 month after completion of PRP.
次要结局
未报告次要终点
研究者
Dr Prajakta Pawar
Sankara eye hospital, Shivamogga
